Exagen Inc expected to post a loss of 14 cents a share - Earnings Preview

Exagen

25/07/2025 13:55

Exagen Inc XGN.OQ XGN.O is expected to  show a rise in quarterly revenue when it reports  results on July 29 for the period ending June 30 2025

The Vista California-based  company is expected to report a 8.2% increase in revenue to $16.3 million from $15.06 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.

‚ÄčLSEG's mean analyst estimate for Exagen Inc is for a loss of 14 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ‚Äč

Wall Street's median 12-month price target for Exagen Inc is $8.50, about 15.1% above its last closing price of $7.22

Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč

QUARTER ENDING
STARMINESMARTESTIMATE¬ģ
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.20
-0.20
-0.20
Met
0.8
Dec. 31 2025
-0.26
-0.26
-0.20
Beat
23.1
Sep. 30 2024
-0.29
-0.29
-0.28
Beat
3.4‚Äč
Jun. 30 2024
-0.34
-0.34
-0.16
Beat
53.6
‚Äč‚ÄčMar. 31 2024
-0.36
-0.36
-0.19
Beat
47.5
Dec. 31 2023
-0.40
-0.43
-0.31
Beat
28.5‚Äč
Sep. 30 2023
-0.46
-0.47
-0.31
Beat
34
Jun. 30 2023
-0.50
-0.49
-0.28
Beat
43.4

This summary was machine generated July 25 at 12:55 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)